2017-2021 Japan HIV/AIDS Diagnostics Market: Emerging Opportunities and Growth Strategies
Complete report $2,300. DataPack (test volumes, sales forecasts, supplier shares) $1,500.
Summary
This report presents detailed analyses of the AIDS diagnostics market in Japan. The report provides test volume and sales forecasts for HIV-1/2/Combo, HIV Ag /HIV NAT, Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments:
Highlights
The report is based on a combination of primary and secondary information sources, including VPGMarketResearchs proprietary database developed during the course of over 100 syndicated studies and numerous proprietary single-client assignments. The database contains information on companies, technologies, products and executives worldwide. Moreover, a comprehensive review of the product and financial literature, business and technical periodicals, and pertinent industry analyst reports was conducted. Contains 250 pages and 7 tables
Summary
This report presents detailed analyses of the AIDS diagnostics market in Japan. The report provides test volume and sales forecasts for HIV-1/2/Combo, HIV Ag /HIV NAT, Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments:
- Hospitals
- Commercial/Private Laboratories
- Blood Banks
Highlights
- Provides scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses.
- Examines market applications of Molecular Diagnostics, Immunodiagnostics, IT and other emerging technologies.
- Reviews infectious disease testing analyzers marketed by Abbott, Beckman Coulter/Danaher, bioMerieux, Ortho-Clinical Diagnostics/J&J, Roche, Siemens, Tosoh and other suppliers.
- Profiles leading manufacturers and potential market entrants developing innovative technologies and products.
- Analyzes alternative market penetration strategies for suppliers.
The report is based on a combination of primary and secondary information sources, including VPGMarketResearchs proprietary database developed during the course of over 100 syndicated studies and numerous proprietary single-client assignments. The database contains information on companies, technologies, products and executives worldwide. Moreover, a comprehensive review of the product and financial literature, business and technical periodicals, and pertinent industry analyst reports was conducted. Contains 250 pages and 7 tables
I. INTRODUCTION
II. A1DS/H4 WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
B. Diagnostic Tests: H4-1/2/Combo, H4Ag/H4 NAT, Western Blot, HTL5-1/2
C. 5accines and Drugs
D. 1nstrumentation Review and Market Needs
E. Emerging Diagnostic Technologies
III. JAPAN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' Sales and Market Shares
IV. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. 1nternal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. MARKET1NG APPROACHES
2. PRODUCT COMPLE11TY
3. CUSTOMER PREFERENCE
4. ESTABL1SHED SUPPL1ERS
5. EMERG1NG SUPPL1ERS
6. MAJOR TYPES OF D1STR1BUTORS
7. MARKET SEGMENTAT1ON
V. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/Gen-Probe
1D Biomedical/GSK
Kreatch/Leica
Lonza
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac/PE
Wako
L1ST OF TABLES
Table 1. Major Companies Developing or Marketing A1DS Tests
Table 2. Japan: H4 or H4-1/2/Combo Test 5olume and Sales Forecast by Market Segment
Table 3. Japan: H4 Ag Test 5olume and Sales Forecast by Market Segment
Table 4. Japan: Western Blot/Other Confirmatory Tests 5olume and Sales Forecast by Market Segment
Table 5. Japan: H4 NAT Blood Screening Test 5olume and Diagnostics Sales
Table 6. Japan: A1DS Diagnostics Market by Major Supplier
Table 7. Japan: H4 Blood Screening NAT Sales and Market Shares of Major Suppliers
II. A1DS/H4 WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
B. Diagnostic Tests: H4-1/2/Combo, H4Ag/H4 NAT, Western Blot, HTL5-1/2
C. 5accines and Drugs
D. 1nstrumentation Review and Market Needs
E. Emerging Diagnostic Technologies
III. JAPAN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' Sales and Market Shares
IV. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. 1nternal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. MARKET1NG APPROACHES
2. PRODUCT COMPLE11TY
3. CUSTOMER PREFERENCE
4. ESTABL1SHED SUPPL1ERS
5. EMERG1NG SUPPL1ERS
6. MAJOR TYPES OF D1STR1BUTORS
7. MARKET SEGMENTAT1ON
V. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/Gen-Probe
1D Biomedical/GSK
Kreatch/Leica
Lonza
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac/PE
Wako
L1ST OF TABLES
Table 1. Major Companies Developing or Marketing A1DS Tests
Table 2. Japan: H4 or H4-1/2/Combo Test 5olume and Sales Forecast by Market Segment
Table 3. Japan: H4 Ag Test 5olume and Sales Forecast by Market Segment
Table 4. Japan: Western Blot/Other Confirmatory Tests 5olume and Sales Forecast by Market Segment
Table 5. Japan: H4 NAT Blood Screening Test 5olume and Diagnostics Sales
Table 6. Japan: A1DS Diagnostics Market by Major Supplier
Table 7. Japan: H4 Blood Screening NAT Sales and Market Shares of Major Suppliers